Ikaria Holdings, a Seattle based company with a Madison medical device business unit, has been acquired by Mallinckrodt Pharmaceuticals. (Apr2015)
Xylome Corporation, an early stage company developing biofuels technologies, recently established an office in the MG&E Innovation Center,and has been added to the database. (Apr2015)
Cellular Dynamics International was acquired by Fujifilm Holdings of Japan for $307 million. They will continue to operate the company in Madison as a wholly owned subsidiary as part of their regenerative medicine portfolio. (May2015)
Innotech Materials, LLC, a start-up company pursuing biomass conversion technologies, has been added to the database. (Mar2015)
AmebaGone Inc., has been added to the database. Founded by Dr. Marcin Filutowicz, the firm is developing a natural approach to overcome antibiotic resistance. (Mar2015)
Neurosolis, Inc., a startup developing therapeutics for CNS disorders, has been added to the database. (Nov 2014)
Hologic - Third Wave technologies has closed its Madison operations, as planned. (Sep 2014) becton Dickinson earlier in 2014 closed its Madison operations as well.
BioTechnique has acquired the former Mentor fill-finish facility and will initiate contract manufacturing services for sterile injectable products by early 2015. It anticipates eventually employing over 100 professionals. (Aug 2014)
POintcare genomics corp., a startup developing a point-of-care diagnostic test for cardiac ischemia, has been added to the database (July 2014).
Elucent Medical, a medical device startup developing a diagnostic device for use in breast cancer surgery and winner of the 2014 Wisconsin Governor's Business Plan Contest, has been added to the database.
HealthMyne, a startup company developing medical imaging technology, has been added to the database.
Novelos Therapeutics was renamed Cellectar Biosciences, Inc. in Feb 2014.
Scientific protein labs agreed in Dec 2013 to be acquired by Shenzhen Hepalink Pharmaceutical Company for $337 million. Hepalink is a leading manufacturer of heparin based in China.
Prairie Technologies, Inc. was acquired by Bruker Corporation in Sep 2013. The company, which had $11 million in 2012 revenue, will continue to operate as a subsidiary of Bruker's Nano Surfaces Division.
GenCell Biosystems Ltd., an Irish medical device company, has opened an office in the University Research Park.
Thermo Fisher Scientific announced in Sep 2013 that they would close their 36 person TREk Diagnostics plant in Sun Prairie by Feb 2014.
Madison VAccines Incorporated, a biopharmaceutical company founded in 2012 that is developing cancer immunotherapeutics, has been added to the database.
Rowheels iNc., a medical device company developing a new ergonomically designed wheel chair, has been added to the database.
Co-d therapeutics, inc., a nano-medicine company founded in 2012 that is developing cancer therapeutics, has been added to the database.
Illumavista Biosciences LLC changed its name in September 2013 to Proteovista LLc
ASthmapolis changed its corporate name and brand to Propeller health in September 2013
NitricGen Inc., one of the 2013 winners of the Governor's Business Plan Contest, has been added to our database. Founded in 2011 by former Ikaria employees, the firm is developing a portable device that produces nitric oxide to treat chronic foot ulcers.
DSM - kensey nash closed its Madison operation at the end of June 2013 in order to consolidate research at an East Coast location. Originally founded as Nerites, the company was acquired by Kensey Nash in 2011, which in turn was purchased by Royal DSM in 2012.
Tasso Inc. is a new Madison company focused on developing at-home diagnostic products.
RE is a Madison startup company founded by Eric Romming, a UW-Madison student. He is developing ReHand, a high-performance prosthetic that can replicate a patient’s lost hand using 3D printing technology.
OpGen TEchnologies Inc. closed its remaining Madison offices in May 2013 in order to focus all of its energies at its East Coast headquarters.
Inviragen Inc., a Colorado based vaccine company with a research site in Madison, was purchased by Takeda Pharmaceuticals of Japan in May 2013. Takeda will pay $35 million up front and up to $215 million in milestones.
Cellara LLC is a newly formed lab equipment company focused on semi-automating cell culture processes. The company is led by Reidar Aamotsbakken and Kevin Conard.
Takeda Vaccines (fka Inviragen) has relocated within Madison from Odana Road to the University Research Park at 504 S. Rosa Road.
Tasso Inc. has moved to 110 E. Main Street (Aug 2014)
nexcyon pharmaceuticals has relocated its headquarters to West Washington Ave Madison (Mar 2014)
Centrose LLC relocated from 902 to 918 Deming Way, Madison (Mar 2014)
Quintessence Biosciences relocated from the University Research Park to 3300 Commercial Avenue, Madison (Jan 2014)